Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.56 |
| ▸ | NOS3 | P29474 | 2/20 | 0.50 |
| ▸ | NOS2 | P35228 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | HTR2A | P28223 | 3/20 | 0.45 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | DRD2 | P14416 | 1/20 | 0.44 |
| ▸ | METAP1 | P53582 | 2/20 | 0.41 |
| ▸ | HTR2C | P28335 | 2/20 | 0.40 |
| ▸ | HTR2B | P41595 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31236843 | 0.86 | IDO1 (0.46) | ACHENOS3NOS2TSHR | |
| SCHEMBL31236844 | 0.86 | IDO1 (0.46) | ACHENOS3NOS2TSHR | |
| SCHEMBL16691536 | 0.78 | ACHE (0.66) | ACHENOS3NOS2TSHRHTR2A | |
| SCHEMBL3054005 | 0.78 | ACHE (0.66) | ACHENOS3NOS2TSHRHTR2A | |
| SCHEMBL8941781 | 0.77 | ACHE (0.59) | ACHENOS3NOS2TSHRHTR2A | |
| SCHEMBL11776080 | 0.75 | ACHE (0.61) | ACHENOS3NOS2TSHRHTR2A | |
| SCHEMBL13802325 | 0.74 | HTR2A (0.45) | ACHENOS3NOS2TSHRHTR2A | |
| SCHEMBL20402534 | 0.74 | PLAU (0.54) | ACHENOS3NOS2TSHRHTR2A | |
| SCHEMBL1699526 | 0.72 | ACHE (0.58) | ACHENOS3NOS2TSHRMETAP1 | |
| SCHEMBL9752693 | 0.72 | ACHE (1.00) | ACHENOS3NOS2TSHRMETAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110046217-A1 | USE OF 2,2'-CYCLOLIGNANS FOR INDUCING, RESTORING OR STIMULATING THE PIGMENTATION OF THE SKIN, HAIR OR HAIRS | GREENTECH (FR) | 2011-02-24 | — | — | US | claimed |
| EP-2190403-A1 | USE OF 2,2'-CYCLOLIGNANES FOR INDUCING, RESTORING OR STIMULATING THE PIGMENTATION OF THE SKIN, HAIR OR HAIRS | Greentech (FR) | 2010-06-02 | — | — | EP | claimed |
| WO-2009027330-A1 | USE OF 2,2'-CYCLOLIGNANES FOR INDUCING, RESTORING OR STIMULATING THE PIGMENTATION OF THE SKIN, HAIR OR HAIRS | GREENTECH (FR) | 2009-03-05 | — | — | WO | claimed |
| US-11540539-B2 | Reduced sodium food products | GENERAL MILLS, INC. (US) | 2023-01-03 | — | — | US | disclosed |
| EP-3732994-B1 | REDUCED SODIUM FOOD PRODUCTS | GEN MILLS INC (US) | 2022-11-09 | — | — | EP | disclosed |
| EP-3466930-B1 | REDUCED SODIUM FOOD PRODUCT | GEN MILLS INC (US) | 2022-07-20 | — | — | EP | disclosed |
| EP-3732994-A1 | REDUCED SODIUM FOOD PRODUCTS | GENERAL MILLS, INC. (US) | 2020-11-04 | — | — | EP | disclosed |
| US-20200281236-A1 | REDUCED SODIUM FOOD PRODUCTS | GEN MILLS INC (US) | 2020-09-10 | — | — | US | disclosed |
| EP-3366677-B1 | REDUCED SODIUM FOOD PRODUCTS | GEN MILLS INC (US) | 2020-09-09 | — | — | EP | disclosed |
| EP-3466930-A1 | REDUCED SODIUM FOOD PRODUCT | GENERAL MILLS, INC. (US) | 2019-04-10 | — | — | EP | disclosed |
| US-20190090520-A1 | REDUCED SODIUM FOOD PRODUCTS | GEN MILLS INC (US) | 2019-03-28 | — | — | US | disclosed |
| WO-2014124201-A1 | REDUCED SODIUM FOOD PRODUCTS | GENERAL MILLS, INC. (US) | 2014-08-14 | — | — | WO | disclosed |
| WO-2014124193-A1 | REDUCED SODIUM FOOD PRODUCTS | GENERAL MILLS, INC. (US) | 2014-08-14 | — | — | WO | disclosed |
| WO-2014124212-A1 | REDUCED SODIUM FOOD PRODUCTS | GENERAL MILLS, INC. (US) | 2014-08-14 | — | — | WO | disclosed |
| US-20110046217-A1 | USE OF 2,2'-CYCLOLIGNANS FOR INDUCING, RESTORING OR STIMULATING THE PIGMENTATION OF THE SKIN, HAIR OR HAIRS | GREENTECH (FR) | 2011-02-24 | — | — | US | disclosed |
| US-20110046217-A1 | USE OF 2,2'-CYCLOLIGNANS FOR INDUCING, RESTORING OR STIMULATING THE PIGMENTATION OF THE SKIN, HAIR OR HAIRS | GREENTECH (FR) | 2011-02-24 | — | — | US | disclosed |
| EP-2190403-A1 | USE OF 2,2'-CYCLOLIGNANES FOR INDUCING, RESTORING OR STIMULATING THE PIGMENTATION OF THE SKIN, HAIR OR HAIRS | Greentech (FR) | 2010-06-02 | — | — | EP | disclosed |
| EP-2190403-A1 | USE OF 2,2'-CYCLOLIGNANES FOR INDUCING, RESTORING OR STIMULATING THE PIGMENTATION OF THE SKIN, HAIR OR HAIRS | Greentech (FR) | 2010-06-02 | — | — | EP | disclosed |
| WO-2009027330-A1 | USE OF 2,2'-CYCLOLIGNANES FOR INDUCING, RESTORING OR STIMULATING THE PIGMENTATION OF THE SKIN, HAIR OR HAIRS | GREENTECH (FR) | 2009-03-05 | — | — | WO | disclosed |
| WO-2009027330-A1 | USE OF 2,2'-CYCLOLIGNANES FOR INDUCING, RESTORING OR STIMULATING THE PIGMENTATION OF THE SKIN, HAIR OR HAIRS | GREENTECH (FR) | 2009-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046217-A1 | USE OF 2,2'-CYCLOLIGNANS FOR INDUCING, RESTORING OR STIMULATING THE PIGMENTATION OF THE SKIN, HAIR OR HAIRS | TYR, MC1R, MCHR2 | ACHE 1310/4885NOS3 1550/4885NOS2 1112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.